<DOC>
	<DOCNO>NCT02800148</DOCNO>
	<brief_summary>To compare bioequivalence Perrigo 's azelaic acid foam product Finacea Foam treatment Inflammatory Lesions Rosacea</brief_summary>
	<brief_title>Bioequivalence Study Two Treatments Treatment Inflammatory Lesions Rosacea Face</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>1 . Subject must sign Institutional Review Board ( IRB ) approve write inform consent study . 2 . Subjects must least 18 year age . 3 . Subjects must definite clinical diagnosis moderate facial papulopustular rosacea , 4 . Subjects must willing able understand comply requirement study , apply medication instruct , refrain use 5 . Subjects must general good health free clinically significant disease , rosacea , might interfere study evaluation . 6 . Females childbearing potential ( exclude woman surgically sterilize ( verified tubal ligation bilateral oophorectomy hysterectomy ) post menopausal least 2 year ) , addition negative urine pregnancy test Visit 1/Day 1 ( Baseline ) , must willing use acceptable form birth control study . 1 . Subjects , pregnant , breastfeeding , plan pregnancy within period study participation . 2 . Current past ocular rosacea 3 . Presence facial skin condition might interfere rosacea diagnosis and/or assessment 4 . Any uncontrolled , chronic serious disease medical condition would prevent participation clinical trial , judgment Investigator , would put subject undue risk might confound study assessment 5 . Currently use product contain Azelaic Acid/or belong family Azelaic Acid foam , 15 % . 6 . Any use Azelaic Acid Foam , 15 % , 1 month ( 30 day ) prior baseline throughout study . 7 . History hypersensitivity allergy FinaceaÂ® ( Azelaic Acid ) Foam , 15 % , and/or ingredient study medication . 8 . Use radiation therapy and/or antineoplastic agent within 90 day prior Visit 1/Day 1 ( Baseline ) . 9 . Current use anticoagulation therapy use throughout study . 10 . Use medicate makeup ( include antiaging makeup ) throughout study 11 . Use study 1 ) systemic steroid , 2 ) topical retinoids face 3 ) antibiotic know impact rosacea 4 ) immunosuppressive agent , immunomodulators ) . 12 . Facial use 1 ) topical steroid , 2 ) topical antiinflammatory agent , 3 ) topical antimycotic , 4 ) topical rosacea treatment 4 ) topical antibiotic . 13 . Use medicate cleanser face throughout study . 14 . Subject consumes excessive alcohol , abuse drug , condition could compromise subject 's ability comply study requirement 15 . Use topical astringent abrasive , medicate topical preparation ( prescription OTC product ) within 2 day prior Visit 1 throughout study . 16 . Use antipruritic ( include antihistamine ) , spa treatment chlorine exposure ( swim etc . ) within 24 hour study visit . 17 . Participation clinical study involve investigational product , agent device might influence intended effect mask side effect study medication 1 month ( 30 day ) prior Visit 1/Day 1 ( Baseline ) throughout study . 18 . Previous enrollment study current enrollment study another participate site . 19 . Use tanning booth , sun lamp ( excessive UV radiation e.g. , phototherapy , daily extend exposure occupational exposure sun ) , sunbathe excessive exposure sun 1 week prior baseline throughout study . 20 . Subjects opinion investigator , unlikely able follow restriction protocol complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>